References
Angello, J. C.; Stern, H. M.; Hauschka, S. D. P19 embryonal carcinoma cells: a model system for studying neural tube induction of skeletal myogenesis. Dev. Biol. 192:93–98; 1997.
Edwards, M. K.; Harris, J. F.; McBurney, M. W. Induced muscle differentiation in an embryonal carcinoma cell line. Mol. Cell. Biol. 3:2280–2286; 1983.
Jones-Villeneuve, E. M.; McBurney, M. W.; Rogers, K. A.; Kalnins, V. I. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol. 94:253–262; 1982.
Jones-Villeneuve, E. M.; Rudnicki, M. A.; Harris, J. F.; McBurney, M. W. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 3:2271–2279; 1983.
McBurney, M. W.; Jones-Villeneuve, E. M.; Edwards, M. K.; Anderson, P. J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299:165–167; 1982.
Ridgeway, A. G.; Petropoulos, H.; Siu, A.; Ball, J. K.; Skerjanc, I. S. Cloning, tissue distribution, subcellular localization and overexpression of murine histidine-rich Ca2+ binding protein. FEBS Lett. 456:399–402; 1999.
Ridgeway, A. G.; Petropoulos, H.; Wilton, S.; Skerjanc, I. S. Wnt signaling regulates the function of MyoD and myogenin. J. Biol. Chem. 275:32,398–32,405; 2000a.
Ridgeway, A. G.; Skerjanc, I. S. Pax3 is essential for skeletal myogenesis and the expression of six1 and eya2. J. Biol. Chem. 276:19,033–19,039; 2001.
Ridgeway, A. G.; Wilton, S.; Skerjanc, I. S. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275:41–46; 2000b.
Rudnicki, M. A.; Jackowski, G.; Saggin, L.; McBurney, M. W. Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells. Dev. Biol. 138:348–358; 1990.
Rudnicki, M. A.; McBurney, M. W. Cell culture methods and induction of differentiation of embryonal carcinoma cell lines. In: Robertson, E. J., ed. Teratocarcinomas and embryonic stem cells. A practical approach. Oxford: IRL Press; 1987:19–49.
Rudnicki, M. A.; Ruben, M.; McBurney, M. W. Regulated expression of a transfected human cardiac actin gene during differentiation of multipotential murine embryonal carcinoma cells. Mol. Cell. Biol. 8:406–417; 1988.
Skerjanc, I. S. Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc. Med. 9:139–143; 1999.
Skerjanc, I. S.; McBurney, M. W. The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle. Dev. Biol. 163:125–132; 1994.
Skerjanc, I. S.; Petropoulos, H.; Ridgeway, A. G.; Wilton, S. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J. Biol. Chem. 273:34,904–34,910; 1998.
Skerjanc, I. S.; Slack, R. S.; McBurney, M. W. Cellular aggregation enhances MyoD-directed skeletal myogenesis in embryonal carcinoma cells. Mol. Cell. Biol. 1464:8451–8459; 1994.
Smith, S. C.; Reuhl, K. R.; Craig, J.; McBurney, M. W. The role of aggregation in embryonal carcinoma cell differentiation. J. Cell. Physiol. 131:74–84; 1987.
Vidricaire, G.; Jardine, K.; McBurney, M. W. Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures. Development 120:115–122; 1994.
Wilton, S.; Skerjanc, I. S. Factors in serum regulate muscle development in P19 cells. In Vitro Cell. Dev. Biol. 35A:175–177; 1999.
Wobus, A. M.; Kleppisch, T.; Maltsev, V.; Hescheler, J. Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels. In Vitro Cell. Dev. Biol. 30A:425–434; 1994.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jamali, M., Karamboulas, C., Wilton, S. et al. Factors in serum regulate Nkx2.5 and MEF2C function. In Vitro Cell.Dev.Biol.-Animal 37, 635–637 (2001). https://doi.org/10.1290/1071-2690(2001)037<0635:FISRNA>2.0.CO;2
Received:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2001)037<0635:FISRNA>2.0.CO;2